Genient Advances Precision Diagnostics for India with Clinical Genomics and AMR-Focused NGS Solutions

Noida (Uttar Pradesh) [India], February 10: Genient, a Noida-based genomics and molecular diagnostics company founded in 2017, is strengthening India's precision healthcare ecosystem by delivering platform-agnostic, India-relevant molecular and next-generation sequencing (NGS) solutions tailored to the country's real disease burden, including infectious diseases, antimicrobial resistance (AMR), oncology, and epigenetics.